CIK 0001799788 · Non-accelerated filer<br>Smaller reporting company
Greenwich LifeSciences, Inc.
Sign in to watch- Ticker
- GLSI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205473709
- Phone
- 203-434-3290
- Business address
- 3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-04 | Patel Snehal CEO and CFO | Purchase | +2,000 | $10.55 | $21K | 5,290,177 |
| 2023-07-21 | Patel Snehal CEO and CFO | Purchase | +1,000 | $9.20 | $9K | 5,288,177 |
| 2023-07-13 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +250 | $9.49 | $2K | 259,248 |
| 2023-05-17 | Patel Snehal CEO and CFO | Purchase | +1,000 | $11.69 | $12K | 5,287,177 |
| 2023-04-28 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +250 | $11.22 | $3K | 258,998 |
| 2023-04-19 | Patel Snehal CEO and CFO | Purchase | +7,000 | $11.10 | $78K | 5,286,177 |
| 2023-04-18 | Patel Snehal CEO and CFO | Purchase | +2,000 | $11.12 | $22K | 5,279,177 |
| 2023-04-11 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +1,000 | $11.87 | $12K | 258,745 |
| 2023-04-11 | Patel Snehal CEO and CFO | Purchase | +5,000 | $12.42 | $62K | 5,271,177 |
| 2023-03-15 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +250 | $12.71 | $3K | 257,745 |
| 2023-03-10 | Patel Snehal CEO and CFO | Purchase | +1,000 | $12.12 | $12K | 2,737,486 |
| 2023-02-24 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +250 | $15.40 | $4K | 257,495 |
| 2023-02-17 | Patel Snehal CEO and CFO | Purchase | +600 | $16.53 | $10K | 2,736,486 |
| 2023-02-10 | Patel Snehal CEO and CFO | Purchase | +1,000 | $18.68 | $19K | 2,735,886 |
| 2023-02-03 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +250 | $20.84 | $5K | 257,245 |
| 2023-01-27 | Patel Snehal CEO and CFO | Purchase | +2,000 | $19.35 | $39K | 2,734,886 |
| 2023-01-27 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +250 | $19.20 | $5K | 256,995 |
| 2023-01-20 | Patel Snehal CEO and CFO | Purchase | +1,500 | $17.37 | $26K | 2,732,886 |
| 2023-01-13 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +250 | $16.50 | $4K | 256,745 |
| 2023-01-06 | Patel Snehal CEO and CFO | Purchase | +1,500 | $15.18 | $23K | 2,731,386 |
Page 4 of 10 · 190 trades